Atherosclerosis is an inflammatory disease characterised by increased expre
ssion of adhesion molecules for leukocytes on both the surface of dysfuncti
onal endothelium and on smooth muscle cells (SMC) within the lesion. It is
also characterised by altered SMC phenotypic expression, indicated by a dec
reased Volume fraction of myofilaments (V(v)myo) [1,2] and changes in gene
expression [3]. The present study used an in vitro model to investigate, by
immunofluorescence staining and flow cytometry, the influence of phenotype
on vascular SMC expression of the adhesion molecule for leukocytes, intrac
ellular adhesion molecule-1 (ICAM-1), and the regulatory mechanisms involve
d in this process. Smooth muscle cells with a high V(v)myo, freshly isolate
d from rat aortic media, expressed little or no ICAM-1 and this could not b
e induced by interleukin-1 beta (IL-1 beta). As SMC modulated phenotype, in
dicated by decreasing V(v)myo over the first 5 days of culture, there was a
concomitant increase in ICAM-1 expression. At day 9 of primary culture, wh
en SMC cultures had returned to the high V(v)myo phenotype, ICAM-1 expressi
on was markedly lower. However, these cells retained the capacity to expres
s ICAM-1 in response to IL-1 beta. After several passages in culture, cells
(with a low V(v)myo) constitutively expressed ICAM-1, with levels further
up-regulated in response to IL-1 beta. These changes in ICAM-1 expression w
ere not related to proliferative state, since similar results were obtained
with growth arrested SMC. Investigation of signalling pathways involved in
regulating ICAM-1 expression by primary vascular SMC suggested a complex r
egulatory mechanism. Activation of adenyl cyclase (with forskolin) caused a
significant increase in cells expressing ICAM-1. Treatment with inhibitors
of protein kinase C (chelerythrine chloride), protein tyrosine kinase (gen
istein), or the transcription factor NF-kappa B (PDTC) had no significant e
ffect on IL-1-induced ICAM-1 expression. However, in the presence of serum,
both genistein and PDTC caused a significant increase in basal expression.
The results indicate that ICAM-1 expression by SMC is phenotype-dependent,
with expression evident only after cells have modulated to a low V(v)myo p
henotype. They also indicate the existence of complex regulatory mechanisms
, possibly involving the SMC cytoskeleton. (C) 2000 Elsevier Science Irelan
d Ltd. All rights reserved.